EFFECTS OF NEUROTENSIN ON REGIONAL BRAIN CONCENTRATIONS OF DOPAMINE, SEROTONIN AND THEIR MAIN METABOLITES

被引:34
作者
DRUMHELLER, AD
GAGNE, MA
STPIERRE, S
JOLICOEUR, FB
机构
[1] UNIV SHERBROOKE,FAC MED,DEPT PSYCHIAT,SHERBROOKE J1H 5N4,QUEBEC,CANADA
[2] INRS,POINTE CLAIRE H9R 1G6,QUEBEC,CANADA
关键词
D O I
10.1016/0143-4179(90)90150-W
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of neurotensin, 7.5 or 30 μg, on concentrations of DA, DOPAC, (HVA), serotonin 5-HT and 5-HIAA were measured in 8 regions of the rat brain either 5 or 30 min following intracerebroventricular administration. Regions examined included the frontal cortex, striatum, nucleus accumbens, amygdala, septum, hypothalamus, ventral tegmentum and substantia nigra. Results indicate that both doses of neurotensin significantly elevated concentrations of dopamine in the striatum and amygdala 5 min following injection. The effects of the peptide on DOPAC and HVA were more pervasive and enduring, with significant increases in metabolite levels occurring in both mesolimbic and nigrostriatal terminal regions. In order to assess effects on turnover of dopamine, the ratios of each metabolic to dopamine concentrations were examined. Results indicate that, while the DOPAC DA ratio was elevated in many regions, the HVA DA ratio was increased in all regions examined. The effects of neurotensin on serotoninergic parameters were less pervasive and more variable, with both increases and decreases in 5-HT and 5-HIAA concentrations being observed. The effects of the peptide on 5-HIAA 5-HT were limited to the nucleus accumbens, where this ratio was increased, and the ventral tegmentum, where 5-HIAA 5-HT was decreased. These findings reveal that the effects of the neurotensin on dopaminergic transmission are more widespread than previously reported in that all major dopamine pathways are affected by the peptide. Also, the observed changes in the ratios of both DOPAC and HVA to DA suggest that neurotensin enhances the turnover of this transmitter. © 1990.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 26 条
  • [1] BANNON MJ, 1983, PHARMACOL REV, V35, P534
  • [2] SEROTONINERGIC MODULATION OF DOPAMINE RESPONSE FROM NUCLEUS ACCUMBENS
    COSTALL, B
    NAYLOR, RJ
    MARSDEN, CD
    PYCOCK, CJ
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (06) : 523 - 526
  • [3] EVIDENCE FOR EXISTENCE OF A RAPHE PROJECTION TO SUBSTANTIA NIGRA IN RAT
    DRAY, A
    GONYE, TJ
    OAKLEY, NR
    TANNER, T
    [J]. BRAIN RESEARCH, 1976, 113 (01) : 45 - 57
  • [4] EFFECTS OF NEUROTENSIN ON REGIONAL CONCENTRATIONS OF NOREPINEPHRINE IN RAT-BRAIN
    DRUMHELLER, AL
    STPIERRE, S
    JOLICOEUR, FB
    [J]. BRAIN RESEARCH BULLETIN, 1986, 16 (05) : 755 - 758
  • [5] THE REGIONAL DISTRIBUTION AND CHROMATOGRAPHIC CHARACTERIZATION OF NEUROTENSIN-LIKE IMMUNOREACTIVITY IN THE RAT CENTRAL NERVOUS-SYSTEM
    EMSON, PC
    GOEDERT, M
    HORSFIELD, P
    RIOUX, F
    STPIERRE, S
    [J]. JOURNAL OF NEUROCHEMISTRY, 1982, 38 (04) : 992 - 999
  • [6] A RAPID METHOD FOR THE REGIONAL DISSECTION OF THE RAT-BRAIN
    HEFFNER, TG
    HARTMAN, JA
    SEIDEN, LS
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1980, 13 (03) : 453 - 456
  • [7] OCCURRENCE OF NEUROTENSINLIKE IMMUNOREACTIVITY IN SUBPOPULATIONS OF HYPOTHALAMIC, MESENCEPHALIC, AND MEDULLARY CATECHOLAMINE NEURONS
    HOKFELT, T
    EVERITT, BJ
    THEODORSSONNORHEIM, E
    GOLDSTEIN, M
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 1984, 222 (04) : 543 - 559
  • [8] RELATIONSHIPS BETWEEN STRUCTURE AND DURATION OF NEUROTENSINS CENTRAL ACTION - EMERGENCE OF LONG-ACTING ANALOGS
    JOLICOEUR, FB
    STPIERRE, S
    AUBE, C
    RIVEST, R
    GAGNE, MA
    [J]. NEUROPEPTIDES, 1984, 4 (06) : 467 - 476
  • [9] THE EFFECTS OF NEUROTENSIN AND [D-TYR11]-NT ON THE HYPERACTIVITY INDUCED BY INTRA-ACCUMBENS ADMINISTRATION OF A POTENT DOPAMINE RECEPTOR AGONIST
    JOLICOEUR, FB
    RIVEST, R
    STPIERRE, S
    GAGNE, MA
    DUMAIS, M
    [J]. NEUROPEPTIDES, 1985, 6 (02) : 143 - 156
  • [10] DIFFERENTIAL NEURO-BEHAVIORAL EFFECTS OF NEUROTENSIN AND STRUCTURAL ANALOGS
    JOLICOEUR, FB
    BARBEAU, A
    RIOUX, F
    QUIRION, R
    STPIERRE, S
    [J]. PEPTIDES, 1981, 2 (02) : 171 - 175